Bluejay Diagnostics Stock Market Value
| BJDX Stock | USD 3.48 0.14 3.87% |
| Symbol | Bluejay |
Bluejay Diagnostics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluejay Diagnostics. If investors know Bluejay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluejay Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (804.00) | Return On Assets (0.59) | Return On Equity (1.25) |
The market value of Bluejay Diagnostics is measured differently than its book value, which is the value of Bluejay that is recorded on the company's balance sheet. Investors also form their own opinion of Bluejay Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Bluejay Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluejay Diagnostics' market value can be influenced by many factors that don't directly affect Bluejay Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluejay Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluejay Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluejay Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bluejay Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bluejay Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bluejay Diagnostics.
| 12/10/2022 |
| 11/29/2024 |
If you would invest 0.00 in Bluejay Diagnostics on December 10, 2022 and sell it all today you would earn a total of 0.00 from holding Bluejay Diagnostics or generate 0.0% return on investment in Bluejay Diagnostics over 720 days. Bluejay Diagnostics is related to or competes with Bone Biologics, Nuwellis, Heart Test, Tivic Health, Nexalin Technology, and IRIDEX. Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monito... More
Bluejay Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bluejay Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bluejay Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 120.52 | |||
| Value At Risk | (13.14) | |||
| Potential Upside | 13.03 |
Bluejay Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bluejay Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bluejay Diagnostics' standard deviation. In reality, there are many statistical measures that can use Bluejay Diagnostics historical prices to predict the future Bluejay Diagnostics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (1.07) | |||
| Total Risk Alpha | (3.05) | |||
| Treynor Ratio | (2.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluejay Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluejay Diagnostics Backtested Returns
Bluejay Diagnostics secures Sharpe Ratio (or Efficiency) of -0.0436, which signifies that the company had a -0.0436% return per unit of risk over the last 3 months. Bluejay Diagnostics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bluejay Diagnostics' Mean Deviation of 6.47, standard deviation of 13.5, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bluejay Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bluejay Diagnostics is expected to be smaller as well. At this point, Bluejay Diagnostics has a negative expected return of -0.6%. Please make sure to confirm Bluejay Diagnostics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Bluejay Diagnostics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Bluejay Diagnostics has average predictability. Overlapping area represents the amount of predictability between Bluejay Diagnostics time series from 10th of December 2022 to 5th of December 2023 and 5th of December 2023 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bluejay Diagnostics price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Bluejay Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 85.7 K |
Bluejay Diagnostics lagged returns against current returns
Autocorrelation, which is Bluejay Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bluejay Diagnostics' stock expected returns. We can calculate the autocorrelation of Bluejay Diagnostics returns to help us make a trade decision. For example, suppose you find that Bluejay Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bluejay Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bluejay Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bluejay Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bluejay Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Bluejay Diagnostics Lagged Returns
When evaluating Bluejay Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bluejay Diagnostics stock have on its future price. Bluejay Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bluejay Diagnostics autocorrelation shows the relationship between Bluejay Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Bluejay Diagnostics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.